Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Signs Up Indiana University Business Students to Commercialize Proteomics Device

NEW YORK, Jan. 14 (GenomeWeb News) - Inproteo and the Indiana University Kelley School of Business have founded a new company, to be run by students and faculty, to help commercialize new proteomics tools.

 

The first product will be an automated sample loader for proteomics research, developed at Eli Lilly and licensed to Inproteo. Shot, a company based in Greenville, Ind., will develop a prototype, which the new company, to be housed at the Indiana University Research Park in Bloomington, expects to bring to market later this year.

 

Inproteo is a consortium between Eli Lilly, IndianaUniversity, and PurdueUniversitythat aims to license new proteomics technologies or spin them off into new companies.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.